Note: Ingredients listed on restricted chemical lists
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
93-14-1
Name of the chemical
Guaifenesin (INN)
Concentration
N/A
EC/CAS
50-70-4
Name of the chemical
D-glucitol C6H14O6
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
5026-62-0
Name of the chemical
4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts
Concentration
N/A
EC/CAS
94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
N/A
EC/CAS
202-222-5
Name of the chemical
Guaifenesin (INN)
Concentration
N/A
EC/CAS
200-061-5
Name of the chemical
D-glucitol C6H14O6
Concentration
N/A
EC/CAS
225-714-1
Name of the chemical
4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts
Concentration
N/A
EC/CAS
202-307-7
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
N/A
General Information
Revision date
2018-05-17
Product name
CONTAC HEAD & CHEST CONGESTION NON-DROWSY LIQUID CAPSULES
Product Synonyms
CONTAC HEAD & CHEST CONGESTION NON-DROWSY LIQUID CAPSULES (CANADA) *
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.3 Other hazards
See section 11 for additional information on health hazards.
